{
    "title": "Moderna begins third phase of trials for vaccine to tackle RSV virus which causes cold-like symptoms using on the same mRNA technology developed for COVID-19 jab",
    "url": "https://www.dailymail.co.uk/health/article-10540029/Moderna-begins-phase-trials-RSV-vaccine-based-mRNA-technology-used-COVID-19-jab.html",
    "date": "2022-02-22",
    "keywords": [
        "vaccine",
        "company",
        "virus",
        "rsv",
        "covid19",
        "moderna",
        "technology",
        "covid",
        "protein",
        "mrna",
        "body",
        "phase",
        "respiratory",
        "coldlike",
        "biotechnology",
        "use",
        "jab",
        "flu",
        "shot",
        "year",
        "share",
        "immune",
        "system",
        "pfizer",
        "tech",
        "plan",
        "tuesday",
        "illness",
        "cambridge",
        "massachusettsbase",
        "age",
        "studythis",
        "part",
        "movement",
        "industry",
        "whole",
        "day",
        "file",
        "photorsv",
        "disease",
        "hospitalization",
        "market",
        "bancel",
        "ceo",
        "statement",
        "candidate",
        "potential",
        "quality",
        "life",
        "highrisk",
        "burden",
        "health",
        "care",
        "systemsbancel",
        "futurersv",
        "riskthe",
        "drop",
        "wisconsin",
        "child",
        "misc",
        "article",
        "platform",
        "instruction",
        "packet",
        "bodys",
        "case",
        "biontech",
        "york",
        "citys",
        "manufacture",
        "shotaround",
        "time",
        "largescale",
        "everyday",
        "medicine",
        "wellmoderna",
        "cancer",
        "wellthe",
        "companys",
        "success",
        "heart",
        "inflammation",
        "pause",
        "expansion"
    ],
    "category": [
        "health"
    ]
}